share_log

Tonix Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer SULLIVAN GREGORY M

SEC announcement ·  Mar 1 06:10
Summary by Futu AI
Gregory M Sullivan, the Chief Medical Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As a result, the number of shares Sullivan holds after the transaction remains unknown.
Gregory M Sullivan, the Chief Medical Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As a result, the number of shares Sullivan holds after the transaction remains unknown.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.